Social recovery therapy in combination with early intervention services for enhancement of social recovery in patients with first-episode psychosis (SUPEREDEN3): a single-blind, randomised controlled trial

David Fowler(Guardian Chemicals (Canada)), Max Birchwood(University of Warwick), Vimal Sharma(University of Chester), Linda Everard(Birmingham and Solihull Mental Health NHS Foundation Trust), Paul McCrone(University of Greenwich), Peter B. Jones(Cambridgeshire and Peterborough NHS Foundation Trust), Paul French(University of Liverpool), Swaran P. Singh(University of Warwick), Jo Hodgekins(University of East Anglia), Tim Amos(University of Bristol), Nick Freemantle(MRC Clinical Trials Unit at UCL), Max Marshall(Centre for Addiction and Mental Health), Anna Lavis(University of Birmingham)
The Lancet Psychiatry
December 11, 2017
Cited by 103


Related Papers